Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Experts are expecting strong performance driven by the continued success of Lilly's blockbuster drugs, particularly its insulin portfolio. However, there are also concerns about potential headwinds fr